Vimarsana
Biggest News Aggregation in the World

Suburban Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Suburban Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Suburban Diagnostics Today - Breaking & Trending Today

For diagnostic companies acquisitions have become integral to growth strategies - Vimarsana News

For diagnostic companies acquisitions have become integral to growth strategies

Vijaya Diagnostic Centre’s latest acquisition follows similar moves by Dr Lal PathLabs and Metropolis Healthcare

Saurabh Mukherjea | Saurabh Mukherjea stocks: 2023 was 'ulta pulta' year; 2024 will be largely about largecaps & FIIs: Saurabh Mukherjea - Vimarsana News

Saurabh Mukherjea | Saurabh Mukherjea stocks: 2023 was 'ulta pulta' year; 2024 will be largely about largecaps & FIIs: Saurabh Mukherjea

" The sheer amount of money foreign investors make wont go into smallcaps so much; it will end up going into the larger stocks and we are hoping that Consistent Compounders will continue to make money from that. We are up 26% this fiscal in CCP. We manage roughly a billion dollars with our clients and we are hoping that as FIIs return, that 26% will be further augmented by FII flows."

Hematology Diagnostic Market Ascending to a Projected US$ 2.0 Billion Valuation by 2033-FMI Study - Vimarsana News

Hematology Diagnostic Market Ascending to a Projected US$ 2.0 Billion Valuation by 2033-FMI Study

The Haematology Diagnostics Market is expected to be worth US$ 780.0 million in 2023 and US$ 2.0 billion by 2033. During the forecast period, the market for haematology diagnostics is expected to grow at a CAGR of 9.9%.Cancer, blood clots, blood-related disorders, and infections are driving market expansion. Further...

Why Dr Lal PathLabs' fat profit margins are bringing no cheer - Vimarsana News

Why Dr Lal PathLabs' fat profit margins are bringing no cheer

Business volumes lagged expectations as patient footfalls are largely unchanged in Q1 FY24 from year ago period

Hematology Diagnostics Market is expected to surpass US$ 2.0 billion by 2033, with a CAGR of 9.9% - Vimarsana News

Hematology Diagnostics Market is expected to surpass US$ 2.0 billion by 2033, with a CAGR of 9.9%

The Hematology Diagnostics Market Size is anticipated to be worth US$ 780.0 million in 2023 and US$ 2.0 billion by 2033. The market for Hematology Diagnostics is estimated to develop at a CAGR of 9.9% during the forecast period.Chronic diseases such as cancer, blood clots, blood-related disorders, and infections are...